CO4910128A1 - Tratamiento del asma y compuestos utiles para este trata- miento ta combinacion y un kit de esta combinacion - Google Patents

Tratamiento del asma y compuestos utiles para este trata- miento ta combinacion y un kit de esta combinacion

Info

Publication number
CO4910128A1
CO4910128A1 CO97063641A CO97063641A CO4910128A1 CO 4910128 A1 CO4910128 A1 CO 4910128A1 CO 97063641 A CO97063641 A CO 97063641A CO 97063641 A CO97063641 A CO 97063641A CO 4910128 A1 CO4910128 A1 CO 4910128A1
Authority
CO
Colombia
Prior art keywords
loratadine
decongestant
treatment
per day
combination
Prior art date
Application number
CO97063641A
Other languages
English (en)
Spanish (es)
Inventor
Alan G Harris
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of CO4910128A1 publication Critical patent/CO4910128A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CO97063641A 1996-10-31 1997-10-29 Tratamiento del asma y compuestos utiles para este trata- miento ta combinacion y un kit de esta combinacion CO4910128A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31

Publications (1)

Publication Number Publication Date
CO4910128A1 true CO4910128A1 (es) 2000-04-24

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
CO97063641A CO4910128A1 (es) 1996-10-31 1997-10-29 Tratamiento del asma y compuestos utiles para este trata- miento ta combinacion y un kit de esta combinacion

Country Status (21)

Country Link
EP (1) EP0941091A1 (no)
JP (1) JP2000505104A (no)
KR (1) KR20000052922A (no)
CN (1) CN1235545A (no)
AR (1) AR008908A1 (no)
AU (1) AU731756B2 (no)
BR (1) BR9712705A (no)
CA (1) CA2268546A1 (no)
CO (1) CO4910128A1 (no)
CZ (1) CZ150999A3 (no)
HU (1) HUP9904075A3 (no)
ID (1) ID23431A (no)
IL (1) IL129662A0 (no)
NO (1) NO992062D0 (no)
NZ (1) NZ335078A (no)
PE (1) PE11399A1 (no)
PL (1) PL333056A1 (no)
SK (1) SK54599A3 (no)
TR (1) TR199901003T2 (no)
WO (1) WO1998018470A1 (no)
ZA (1) ZA979731B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999021556A1 (en) * 1997-10-29 1999-05-06 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
CO5271713A1 (es) * 1998-09-10 2003-04-30 Schering Corp Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando antihistaminas
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
KR100505899B1 (ko) * 1999-02-23 2005-08-01 주식회사유한양행 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
ATE253354T1 (de) * 1999-02-23 2003-11-15 Yuhan Corp Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen
AU3924500A (en) * 1999-03-29 2000-10-16 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
WO2001045676A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Extended release oral dosage composition
WO2001045668A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
WO2001078782A1 (en) * 2000-04-14 2001-10-25 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
PE20020055A1 (es) * 2000-05-25 2002-02-12 Schering Corp Formulaciones estables liquidas y solidas que comprenden una antihistamina no sedante y un descongestionante nasal
CN1518448A (zh) * 2001-06-20 2004-08-04 ���鹫˾ 用于治疗鼻充血和鼻塞的抗组胺剂
CA2612179C (en) 2005-06-17 2016-08-02 Aft Pharmaceuticals Limited A pharmaceutical composition comprising loratadine and its use to treat patients with upper respiratory mucosal congestion
BRPI0712532A2 (pt) * 2006-06-01 2013-04-02 Schering Plough Healthcare Prod Inc formulaÇÕes e composiÇÕes farmacÊuticas de fenilefrina para absorÇço colânica
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
KR101540191B1 (ko) * 2014-02-24 2015-07-28 성균관대학교산학협력단 로라타딘을 포함하는 항염증용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
ZA979731B (en) 1998-04-29
NO992062L (no) 1999-04-29
JP2000505104A (ja) 2000-04-25
AR008908A1 (es) 2000-02-23
CN1235545A (zh) 1999-11-17
ID23431A (id) 2000-04-20
KR20000052922A (ko) 2000-08-25
SK54599A3 (en) 2000-08-14
HUP9904075A3 (en) 2002-02-28
TR199901003T2 (xx) 1999-07-21
BR9712705A (pt) 1999-10-26
CZ150999A3 (cs) 1999-10-13
CA2268546A1 (en) 1998-05-07
HUP9904075A2 (hu) 2000-05-28
WO1998018470A1 (en) 1998-05-07
NZ335078A (en) 2000-10-27
AU731756B2 (en) 2001-04-05
AU4995397A (en) 1998-05-22
IL129662A0 (en) 2000-02-29
PE11399A1 (es) 1999-02-09
NO992062D0 (no) 1999-04-29
PL333056A1 (en) 1999-11-08
EP0941091A1 (en) 1999-09-15

Similar Documents

Publication Publication Date Title
CO4910128A1 (es) Tratamiento del asma y compuestos utiles para este trata- miento ta combinacion y un kit de esta combinacion
EA200700232A1 (ru) Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения
IS3959A (is) Aðferð við framleiðslu á blöndu sem samanstendur af lyfi sem er berkjuvíkkandi og bólgueyðandi steralyfi til meðhöndlunar á öndunartruflunum og notkun hennar
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
AR033548A1 (es) Composicion farmaceutica que comprende un inhibidor de lipasa, un procedimiento para su preparacion, equipo transportable a modo de ''kit'', el uso de dicha composicion en la fabricacion de medicamentos, un inhibidor de lipasa y un secuestrante de acidos biliares
PT1446119E (pt) Substancias que contem ipratropio e xilometazolina na sua composicao para o tratamento da constipacao comum
HUP0100437A2 (hu) Szabályzott felszabadulású gyógyszerkészítmény tolterodin adagolására
CL2009001279A1 (es) Compuestos derivados de nociceptina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor (sol. divisional 2103-03).
BR9714082A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto.
GT199700009AA (es) Terapia combinada para la osteoporosis
PT797991E (pt) Formulacao com libertacao prolongada contendo venlafaxina
DE60021749D1 (de) Pharmazeutische formulierung enthaltend tolterodin sowie ihre verwendung
WO2004039320A3 (en) STEREOISOMERS OF p-HYDROXY-MILNACIPRAN, AND METHODS OF USE THEREOF
CA2400217A1 (en) Pteridine compounds for the treatment of psoriasis
AR013506A1 (es) Uso de una composicion farmaceutica para la manufactura de un medicamento para ser usado en el tratamiento de enfermedades de obstruccion pulmonarcronica y de un kit que comprende formoterol o una sal o solvato del mismo y budesonida
ES2109899T1 (es) Metodo, composiciones y kits para aumentar la biodisponibilidad oral de agentes farmaceuticos.
AR006652A1 (es) Forma farmacéutica de dosificación oral para el tratamiento oral de enfermedades óseas.
BR0213293A (pt) Uso de tfpi ou de um análogo de tfpi no tratamento de septicemia
AR011106A1 (es) COMPOSICIoN FARMACÉUTICA PARA EL TRAMIENTO O PREVENCI.ON DE LA DIABETES MELLITUS TIPO 2,
BRPI0107493B8 (pt) substâncias para uso no tratamento de psoríase
AR023687A1 (es) Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
HUP0204097A2 (hu) Guanozin-3',5'-monofoszfát-foszfodiészteráz inhibitorok alkalmazása diabetikus fekélyek kezelésére szolgáló készítmények előállítására
BR9911005A (pt) Uso de ozÈnio para a preparação de medicamentos para o tratamento de cáries dentárias
BR9713514A (pt) Novo uso de creatina